THE PRIVILEGE OF BEING ABLE TO HAVE DREAMS, IDEAS AND GOALS COME TO FRUITION, IS THE CORE OF WHAT WE ARE ABLE TO EXPERIENCE BECAUSE OF THE FREEDOMS THAT ARE OURS IN AMERICA.

- Denise Burnett Stewart

SMALL BUSINESS DRIVES THE AMERICAN ECONOMY. IT THRIVES AND SURVIVES NO MATTER WHAT MAY BE GOING ON IN THE MAIN ECONOMY.

- Dick Gadomski

UNLESS WE PROMOTE ENTREPRENEURSHIP, WE WILL NOT HAVE AN EXCITING BUSINESS ATMOSPHERE IN OUR COUNTRY.

- Allen B. Morgan, Jr.

Steve Charles MD

Charles Retina Institute
Founder & CEO
Entrepreneur

Steve Charles, MD is the world’s leading vitreoretinal surgeons and has developed many of the techniques and devices used by vitreoretinal surgeons worldwide. He has performed over 36,000 vitreoretinal surgeries, lectured in 50 countries and operated in 25, delivered 17 named lectures, and over 1000 speaking trips. He authored a leading textbook in the field which is now in the 5th edition and in 6 languages and authored over 174 articles in the medical literature and over 50 book chapters. He is a Fellow in the American College of Surgeons and International College of Surgeons and a member of the Retina Society, Macular Society, American Society of Retinal Specialists, Club Jules Gonin, American Society of Cataract and Refractive Surgery, American Academy of Ophthalmology, American-European College of Ophthalmic Surgery, Euro-Lam, and the Dowling Society. He is on the Board of Governors of the ARVO Foundation for Eye Research He is on the editorial board of Retina and a reviewer for Ophthalmology, Archives of Ophthalmology, American Journal of Ophthalmology, and British Journal of Ophthalmology, writes a column for Retina Physician and is an editor for eMedicine. He has received the Wacker Medal from the Club Jules Gonin, the first Founders Medal from the Vitreous Society, was inducted into the University of Miami School of Medicine Medical Alumni Association Hall of Fame, and was named by Ocular Surgery News as one of the top ten innovators in the past 25 years. He is consistently listed in Best Doctors in America and Becker’s Top 34 Ophthalmologists in America. He is a Clinical Professor of Ophthalmology at the University of Tennessee.

He is a mechanical and electrical engineer and has well over 100 issued or pending patents. He is a consultant for Alcon Laboratories and the principal architect of the Alcon Accurus and Alcon Constellation Vision System. Alcon also acquired InnoVision, a company started by Dr Charles, the Alcon Accurus and Constellation product lines are derivatives of InnoVision technology invented by Dr Charles.
He is the Founder of MicroDexterity Systems, which developed robots for dexterity enhancement for minimally invasive knee and hip replacement, spine surgery, and skull base neurosurgery. Investors included Medtronic, Baxter, and Allegiance V.Mueller. Stryker, Inc. acquired MicroDexterity Systems, in December 2009.

He is a cofounder, systems engineer, largest investor & stockholder, and Chairman of CamPlex Inc, developing advanced visualization technology for MIS spine, neurosurgery and trans-oral approaches to head and neck cancer.

He is on the board of Zeroto510, a medical device seed capital firm based in Memphis. Dr. Charles is volunteer with Orbis, the Flying Eye Hospital is the world’s only mobile ophthalmic teaching hospital.

Steve Charles is an Airline Transport Pilot, Multi-Engine, Instrument rated pilot with Type Ratings in Citation 500, 560, 650, Falcon 50and Sabre 65 jets and currently owns and flies a Sabre 65.

Description of Business:

Group private practice, vitreoretinal surgery (ophthalmology)

Thoughts on Entrepreneurship:

“I have started or helped start 5 medical device companies; the purpose in each instance was to provide needed medical technology not financial return for me or because of the challenge. Large medical device companies are very conservative with respect to innovation but have the capital, manufacturing, regulatory and distribution channel capabilities which are near impossible to build with venture backing. Building relationships with strategics hopefully leading to acquisition and growth in the marketplace has been the approach I have taken. A major challenge is the cultural and motivational differences between my goal of better medical outcomes and purely financial people and enitities.”